ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,10192
-0,05%
Bitcoin
66.622,50
-0,47%
Brent Oil
83,76
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Cymabay Therapeutics Inc (CBAY)

  7. Cymabay Therapeutics Inc (CBAY) Notícias

CBAY

Cymabay Therapeutics (CBAY)

Cymabay Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CBAY
DataHoraFonteTítuloCódigoCompanhia
22/03/202410:18Business WireGilead Sciences Announces Completion of Acquisition of CymaBayNASDAQ:CBAYCymabay Therapeutics Inc
11/03/202410:14Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
23/02/202408:25Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:CBAYCymabay Therapeutics Inc
16/02/202419:14Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CBAYCymabay Therapeutics Inc
15/02/202418:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
14/02/202420:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBAYCymabay Therapeutics Inc
14/02/202418:46Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CBAYCymabay Therapeutics Inc
14/02/202414:50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CBAYCymabay Therapeutics Inc
12/02/202415:43PR Newswire (US)Kuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to Contact Law FirmNASDAQ:CBAYCymabay Therapeutics Inc
12/02/202410:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CBAYCymabay Therapeutics Inc
07/11/202318:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CBAYCymabay Therapeutics Inc
23/10/202313:52Dow Jones NewsCymaBay Shares Rise 7% After Revised Breakthrough Therapy DesignationNASDAQ:CBAYCymabay Therapeutics Inc
12/09/202317:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CBAYCymabay Therapeutics Inc
10/08/202318:10Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CBAYCymabay Therapeutics Inc
10/08/202317:51Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CBAYCymabay Therapeutics Inc
23/06/202317:52Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CBAYCymabay Therapeutics Inc
23/06/202317:49Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:CBAYCymabay Therapeutics Inc
21/06/202319:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBAYCymabay Therapeutics Inc
21/06/202307:00Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:CBAYCymabay Therapeutics Inc
06/06/202317:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBAYCymabay Therapeutics Inc
15/05/202317:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBAYCymabay Therapeutics Inc
26/04/202317:16Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CBAYCymabay Therapeutics Inc
19/04/202317:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBAYCymabay Therapeutics Inc
19/04/202317:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CBAYCymabay Therapeutics Inc
10/03/202316:06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CBAYCymabay Therapeutics Inc
14/02/202318:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CBAYCymabay Therapeutics Inc
16/11/202210:10TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:CBAYCymabay Therapeutics Inc
16/11/202204:56TipRanksCymaBay Therapeutics (CBAY) Receives a Buy from SVB SecuritiesNASDAQ:CBAYCymabay Therapeutics Inc
15/11/202208:35TipRanksCymaBay Therapeutics (CBAY) Gets a Buy from H.C. WainwrightNASDAQ:CBAYCymabay Therapeutics Inc
26/09/202200:21TipRanksAnalysts Are Bullish on These Healthcare Stocks: CymaBay Therapeutics (CBAY), Vir Biotechnology (VIR)NASDAQ:CBAYCymabay Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CBAY

Seu Histórico Recente

BIT
LVEN
LVenture
BOV
RADLE242
RADLE242 Ex:24,12
BOV
MCRJ11B
CEPAC MCRJ CPA MB
LSE
0K3S
Murphy Oil
LSE
0DYX
Ubs-etf Sbi Foreign Aaa-...
LSE
0MGR
Forvia
NASDAQ
AREC
American Resources
LSE
FSFL
Foresight Solar
LSE
UOG
United Oil & Gas
NYSE
RRMS
LSE
RRR
Red Rock Resources
BOV
CSED3M
Cruzeiro do Sul Educacio... ON
NYSE
QBTS
D Wave Quantum
BOV
USIME820
USIME820 Ex:7,92
LSE
VENN
Venn Life Sciences
LSE
RTOP
Regtech Open Project
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados